MAKING SCIENCE GROUP SA (ALMKS.PA) Fundamental Analysis & Valuation

EPA:ALMKS • ES0105463006

Current stock price

7.9 EUR
0 (0%)
Last:

This ALMKS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALMKS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMKS has reported negative net income.
  • ALMKS had a positive operating cash flow in the past year.
  • ALMKS had negative earnings in 4 of the past 5 years.
  • Of the past 5 years ALMKS 4 years had a positive operating cash flow.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • ALMKS has a worse Return On Assets (-0.99%) than 63.64% of its industry peers.
  • With a Return On Equity value of -6.62%, ALMKS is not doing good in the industry: 65.15% of the companies in the same industry are doing better.
  • ALMKS has a better Return On Invested Capital (7.51%) than 71.21% of its industry peers.
Industry RankSector Rank
ROA -0.99%
ROE -6.62%
ROIC 7.51%
ROA(3y)-2.49%
ROA(5y)-1.44%
ROE(3y)-23.01%
ROE(5y)-9.95%
ROIC(3y)N/A
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 100 150

1.3 Margins

  • The Operating Margin of ALMKS (1.86%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of ALMKS has declined.
  • ALMKS has a worse Gross Margin (20.80%) than 78.79% of its industry peers.
  • ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.86%
PM (TTM) N/A
GM 20.8%
OM growth 3YN/A
OM growth 5Y-6.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.93%
GM growth 5Y-5%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20

2

2. ALMKS.PA Health Analysis

2.1 Basic Checks

  • ALMKS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ALMKS has more shares outstanding
  • ALMKS has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALMKS has an improved debt to assets ratio.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • ALMKS has an Altman-Z score of 1.71. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.71, ALMKS is doing good in the industry, outperforming 60.61% of the companies in the same industry.
  • ALMKS has a debt to FCF ratio of 1140.00. This is a negative value and a sign of low solvency as ALMKS would need 1140.00 years to pay back of all of its debts.
  • ALMKS's Debt to FCF ratio of 1140.00 is on the low side compared to the rest of the industry. ALMKS is outperformed by 65.15% of its industry peers.
  • A Debt/Equity ratio of 0.46 indicates that ALMKS is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.46, ALMKS is in the better half of the industry, outperforming 62.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1140
Altman-Z 1.71
ROIC/WACC1.1
WACC6.81%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.76 indicates that ALMKS may have some problems paying its short term obligations.
  • ALMKS's Current ratio of 0.76 is on the low side compared to the rest of the industry. ALMKS is outperformed by 69.70% of its industry peers.
  • A Quick Ratio of 0.73 indicates that ALMKS may have some problems paying its short term obligations.
  • ALMKS has a Quick ratio of 0.73. This is in the lower half of the industry: ALMKS underperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.73
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. ALMKS.PA Growth Analysis

3.1 Past

  • ALMKS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.58%, which is quite impressive.
  • Looking at the last year, ALMKS shows a quite strong growth in Revenue. The Revenue has grown by 16.22% in the last year.
  • The Revenue has been growing by 51.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)61.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.33%
Revenue 1Y (TTM)16.22%
Revenue growth 3Y35.39%
Revenue growth 5Y51.26%
Sales Q2Q%21.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.86% on average over the next years. This is quite good.
  • ALMKS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.57% yearly.
EPS Next Y-39.39%
EPS Next 2Y5.89%
EPS Next 3Y14.86%
EPS Next 5YN/A
Revenue Next Year36.31%
Revenue Next 2Y27.02%
Revenue Next 3Y22.57%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

1

4. ALMKS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALMKS. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 38.73, the valuation of ALMKS can be described as expensive.
  • ALMKS's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. ALMKS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 38.73
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALMKS is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, ALMKS is valued a bit more expensive than 65.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1436.22
EV/EBITDA 8.89
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ALMKS's earnings are expected to grow with 14.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.89%
EPS Next 3Y14.86%

3

5. ALMKS.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.32%, ALMKS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 3.42, ALMKS has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.83, ALMKS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALMKS.PA Yearly Dividends per shareALMKS.PA Yearly Dividends per shareYearly Dividends per share 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y5.89%
EPS Next 3Y14.86%
ALMKS.PA Yearly Income VS Free CF VS DividendALMKS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

ALMKS.PA Fundamentals: All Metrics, Ratios and Statistics

MAKING SCIENCE GROUP SA

EPA:ALMKS (4/10/2026, 7:00:00 PM)

7.9

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-19
Earnings (Next)N/A
Inst Owners4.21%
Inst Owner ChangeN/A
Ins Owners58.8%
Ins Owner ChangeN/A
Market Cap71.81M
Revenue(TTM)274.00M
Net Income(TTM)-1.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 38.73
P/S 0.26
P/FCF 1436.22
P/OCF 217.61
P/B 2.76
P/tB N/A
EV/EBITDA 8.89
EPS(TTM)-0.2
EYN/A
EPS(NY)0.2
Fwd EY2.58%
FCF(TTM)0.01
FCFY0.07%
OCF(TTM)0.04
OCFY0.46%
SpS30.14
BVpS2.86
TBVpS-4.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.99%
ROE -6.62%
ROCE 10.22%
ROIC 7.51%
ROICexc 13.46%
ROICexgc N/A
OM 1.86%
PM (TTM) N/A
GM 20.8%
FCFM 0.02%
ROA(3y)-2.49%
ROA(5y)-1.44%
ROE(3y)-23.01%
ROE(5y)-9.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-6.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.93%
GM growth 5Y-5%
F-Score6
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 1140
Debt/EBITDA 1.03
Cap/Depr 4.29%
Cap/Sales 0.1%
Interest Coverage 1.14
Cash Conversion 2.84%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.73
Altman-Z 1.71
F-Score6
WACC6.81%
ROIC/WACC1.1
Cap/Depr(3y)13.72%
Cap/Depr(5y)311.76%
Cap/Sales(3y)0.4%
Cap/Sales(5y)7.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-323.33%
EPS Next Y-39.39%
EPS Next 2Y5.89%
EPS Next 3Y14.86%
EPS Next 5YN/A
Revenue 1Y (TTM)16.22%
Revenue growth 3Y35.39%
Revenue growth 5Y51.26%
Sales Q2Q%21.45%
Revenue Next Year36.31%
Revenue Next 2Y27.02%
Revenue Next 3Y22.57%
Revenue Next 5YN/A
EBIT growth 1Y278.77%
EBIT growth 3YN/A
EBIT growth 5Y41.58%
EBIT Next Year145.61%
EBIT Next 3Y41.06%
EBIT Next 5YN/A
FCF growth 1Y103.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y178.57%
OCF growth 3Y-64.23%
OCF growth 5YN/A

MAKING SCIENCE GROUP SA / ALMKS.PA Fundamental Analysis FAQ

What is the fundamental rating for ALMKS stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALMKS.PA.


Can you provide the valuation status for MAKING SCIENCE GROUP SA?

ChartMill assigns a valuation rating of 1 / 10 to MAKING SCIENCE GROUP SA (ALMKS.PA). This can be considered as Overvalued.


How profitable is MAKING SCIENCE GROUP SA (ALMKS.PA) stock?

MAKING SCIENCE GROUP SA (ALMKS.PA) has a profitability rating of 2 / 10.